Bristol Myers CFD 거래 - 실시간 차트

안녕하세요, user_no_name

지금 거래하기

입금

로그아웃
로그인 회원가입
KO

언어

English English (Global)

English English (EU)

English English (UK)

English English (AU)

English English (ZA)

English English (St. Vincent)

Deutsch German

Español Spanish (Latam)

Español Spanish (Spain)

Français French

Dansk Danish

Italiano Italian

Nederlands Dutch

العربية Arabic

Svenka Swedish

Tiếng việt Vietnamese

Bahasa Melayu Malay

ภาษาไทย Thai

繁體中文 Traditional Chinese

简体中文 Simplified Chinese

Tagalog Tagalog

தமிழ் Tamil

हिन्दी Hindi

Português Portuguese

Bahasa Indonesia Indonesian

한국어 Korean

English English (BVI)
시장

상품

외환

주식

원자재

지수

암호화폐

ETF

채권
거래

거래 플랫폼

웹 플랫폼

앱

TradingView

MT4

MT5

Trading Central

거래 도구

CFD 거래 계산기

외환 증거금 계산기

원자재 수익 계산기

외환 수익 계산기

경제 캘린더

거래 정보

CFD 거래

CFD 자산 목록

거래 조건

거래 시간

만기일

휴장 일정

주간 만기 롤오버

트레이딩 기능

마켓 댑스
학습

트레이딩 배우기

교육 센터

트레이딩 기초

뉴스 & 분석

뉴스
프로모션

마켓츠클럽

웰컴 보너스

추천 보너스
파트너십

제휴

IB
소개

markets.com 소개

markets.com 이용 혜택

글로벌 서비스 제공

그룹 소개

어워드 및 미디어

도움말 & 고객센터

지원 문의하기

고객의 소리

데이터 & 보안

온라인 안전

쿠키 공개

법률 모음집

법률 모음집

규제

검색

언어

로그인 회원가입

BristolMyers 실시간 차트

5m 15m 30m 1h 4h 1d 1w

상품 기초

과거 데이터

날짜	종료	변경	변동(%)	열기	높음	낮음

BristolMyers news

Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices

Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices

Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

정보

스프레드

0.29

스프레드(%)

0.6270 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

월요일

13:31 - 19:59

화요일

13:31-19:59

수요일

13:31-19:59

목요일

13:31-19:59

금요일

13:31-19:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

94529462272

발행 주식 수

2035079936

수익 날짜 (다음)

2001-08-07

배당수익률

2025-05-01

배당락일

2025-04-04

예상 연간 배당금

2.48

예상 연간 배당수익률

0.0521

EPS

2.68

이 상품에 대해 자세히 알아보기

Bristol Myers Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.